AMERISAFE (AMSF) Stock Fair Value Moves Lower After Softer Q3 And Analyst Caution

AMERISAFE's updated valuation work now points to a fair value estimate of US$31.67, down from US$35.67, which is roughly an 11% cut to the modelled price target. Analysts link this shift to softer Q3 results and a more cautious stance on execution, even as they continue to highlight underwriting quality, capital returns and operating discipline. As you read on, you will see how this evolving analyst narrative around AMERISAFE may shape the way you track the stock from here.

Analyst Price Targets don't always capture the full story. Head over to our Company Report to find new ways to value AMERISAFE.

What Wall Street Has Been Saying

🐂 Bullish Takeaways

• Citizens keeps an Outperform rating on AMERISAFE even after trimming its price target, which signals ongoing confidence in the company's franchise despite softer Q3 results.

• Citizens points to stable loss ratios, favorable prior period development and strong capital returns for AMERISAFE, which it expects to support mid to high teens ROEs over time.

• The Citizens research also highlights rational competition, agent focused improvements, favorable wage trends and infrastructure investments as factors that can support future growth for the stock.

🐻 Bearish Takeaways

• Both Citizens and Truist have cut their AMERISAFE price targets, with Citizens moving from US$42 to US$35 and Truist from US$32 to US$27, which marks a reset in Street expectations on valuation.

• Truist maintains a Hold rating and has reduced its Q3 EPS view, citing steady operating expenses, while Citizens references broader sector headwinds such as rising rates and casualty reserve risk that could affect sentiment toward insurers including AMERISAFE.

Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there's more to the story. Head to the Simply Wall St Community to discover more perspectives!

We've flagged 2 risks for AMERISAFE. See which could impact your investment.

How This Changes the Fair Value For AMERISAFE

• The fair value estimate for AMERISAFE has moved from US$35.67 to US$31.67, representing an 11% reduction in the modelled figure.

• The revenue growth assumption has changed from 2.73% to 3.59%.

• The net profit margin assumption has changed from 7.11% to 8.29%.

• The future P/E assumption has moved from 29.58x to 22.09x.

• The discount rate remains effectively unchanged at about 7.24%.

Never Miss an Update: Follow The Narrative

Narratives link AMERISAFE's business story to analyst forecasts and a fair value framework. They update as new earnings, guidance and industry data come through so you can see how the thesis is evolving.